400 ​ 401

AstraZeneca costs Seven Lives due to Blood Clotting

 

Photo Credit: BBC
 

London (Web Desk – 4 April 2021) In the UK, seven people who complained of blood clots after using the corona vaccine, developed by Oxford University and AstraZeneca, died during treatment.

According to the World News Agency, the UK's medical watchdog has confirmed that seven of the 30 people who developed blood clotting after being vaccinated with the coronavirus vaccine of AstraZeneca died during treatment.

A statement from the British Medicine and Healthcare Products Regulatory Agency said: The process will continue.

On the other hand, a report published in the British newspaper Guardian, quoting a panel of haematologists, revealed that the benefits of the AstraZeneca vaccine far outweigh its disadvantages.

Also Read: J&J disposes off 15M vaccines

Dr June Raine, chief executive of the UK's Drug Regulatory Authority, says the coronavirus vaccine from AstraZeneca is helping to control the epidemic, so people should be vaccinated when asked to do so. Dr. June Raine has instructed health professionals to immediately report any abnormalities caused by the Corona virus vaccine on the Corona Government website.

Many countries, including France, Germany, Italy, Canada, Australia and Denmark, had initially suspended the Corona vaccination campaign in Australasia over blood clotting complaints, but some countries resumed vaccination if blood clotting was not proven. Started

The World Health Organization (WHO) and the European Drug Regulatory Authority (ERA) have rejected AstraZeneca's coronavirus vaccine for blood clotting, saying there is no scientific evidence yet. The people who started the blood clotting process were already suffering from a disease.

Medical experts say that the process of blood clotting is natural and abnormal, which also occurs in patients suffering from corona virus. Cases of blood clotting have been reported in Europe since the vaccine was administered, but this does not mean that it is due to the vaccine.

 

0 comments:

Post a Comment